Jodi E. Gustave, Joseph A. Jurcisek, Karen S. McCoy, Steven D

Slides:



Advertisements
Similar presentations
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response  Helle Krogh Johansen, Kasper.
Advertisements

J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Gram-positive infections: lessons learnt and novel solutions
Christopher C. Miller, Christopher A
Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with Cystic Fibrosis  E.
Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients  E. Sans-Serramitjana, E. Fusté, B. Martínez-Garriga,
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response  Helle Krogh Johansen, Kasper.
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis  Jiangchao Zhao, Charles R. Evans, Lisa A. Carmody,
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Amanda L. Brennan, Khin M. Gyi, David M
Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations  Melanie Chin, Maya De Zoysa, Robert.
A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF  Christina Schjellerup Dalbøge, Tacjana.
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Cynthia M. Ward, Tara Brinkman, Keith J. Slifer, Shruti M. Paranjape 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Bacterial resistance—the clinical challenge
Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients  J.L. Fothergill,
Strategies for managing today's infections
Implementation of European standards of care for cystic fibrosis ��� Control and treatment of infection  J.S. Elborn, M. Hodson, C. Bertram  Journal of.
A.H. Gifford  Journal of Cystic Fibrosis 
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas.
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions  Gerard McCaughey,
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
G.C. Schito  Clinical Microbiology and Infection 
CFTR modulators and pregnancy: Our work has only just begun
Patient segregation and aggressive antibiotic eradication therapy can control methicillin- resistant Staphylococcus aureus at large cystic fibrosis centres 
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Treatment intensity and characteristics of MRSA infection in CF
D.A. Robinson, M.C. Enright  Clinical Microbiology and Infection 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Segregation—the perspectives of young patients and their parents
Safety assessment of inhaled xylitol in subjects with cystic fibrosis
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis  Jodi E. Gustave, Joseph A. Jurcisek, Karen S. McCoy, Steven D. Goodman, Lauren O. Bakaletz  Journal of Cystic Fibrosis  Volume 12, Issue 4, Pages 384-389 (July 2013) DOI: 10.1016/j.jcf.2012.10.011 Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Representative image of immunohistochemical labeling for IHF (see punctate area of red fluorescent labeling in image and as indicated by arrows in inset) in OCT-embedded CF sputum samples. 10μm section. Note: both Pseudomonas aeruginosa and methicillin resistant Staphylococcus aureus (MRSA) were cultured from this sample. Journal of Cystic Fibrosis 2013 12, 384-389DOI: (10.1016/j.jcf.2012.10.011) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Representative images taken before and after 1h incubation with either saline, anti-IHF (1:10), DNase (1:10), or a combination of anti-IHF and DNase demonstrating the disruption of the sputum sample and increase in turbidity of the incubation solution. Journal of Cystic Fibrosis 2013 12, 384-389DOI: (10.1016/j.jcf.2012.10.011) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Mean absorbance readings of solution surrounding sputum solids as obtained after incubation of six divided CF sputum samples for 1h with either saline, anti-IHF (1:10), DNase (1:10) or a combination of these latter two agents. * denotes significant difference (p≤0.05) compared to saline, whereas ** denotes significance at p≤0.001. Journal of Cystic Fibrosis 2013 12, 384-389DOI: (10.1016/j.jcf.2012.10.011) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions